Press Release

Xylem reports strong quarter with eight percent growth in organic revenue and orders; double-digit growth in 3rd quarter 2018 earnings

October 30, 2018
  • Third quarter 2018 reported net income was $130 million or $0.72 per share; Adjusted net income for the quarter was $139 million or $0.77 per share, up 18 percent versus the prior year period
  • Xylem delivered $1.3 billion in third quarter 2018 revenue, up eight percent year-over-year excluding the impact of foreign exchange and acquisitions
  • Reported and adjusted EBITDA margin increased 150 and 110 basis points, respectively
  • Company narrows full-year earnings outlook to reflect strong year-to-date performance and negative impact of foreign currency translation

RYE BROOK, N.Y.--(BUSINESS WIRE)--Oct. 30, 2018-- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter 2018 net income of $130 million, or $0.72 per share. Excluding the impact of restructuring, realignment and other special items, the Company delivered adjusted net income of $139 million or $0.77 per share in the quarter, an 18-percent increase over the prior year period. Third quarter revenue was $1.3 billion, up eight percent excluding the impact of foreign exchange and acquisitions. Revenue for the quarter increased eight percent on an organic basis, driven by continued strong growth in all end markets and across all major geographies. Orders also increased eight percent organically for the second consecutive quarter. Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin improved by 110 basis points year-over-year to 20.3 percent driven by volume leverage, savings from productivity initiatives and price realization. Reported operating margin in the quarter was 13.7 percent and adjusted operating margin increased 50 basis points year over year to 14.6 percent, including a 20-basis-point negative impact due to purchase accounting.

Patrick Decker, President and Chief Executive Officer of Xylem, said, “Our team delivered another quarter of strong results, positioning us well to meet our long-term growth and financial commitments. The organic growth we delivered in revenue and orders reflects strong performance in each of our major geographies and across all end markets. We see momentum strengthening in our ongoing efforts to drive commercial excellence and leverage our expanded portfolio, which are yielding more wins and share gains. Our focus on executing productivity initiatives and realizing additional pricing has enabled us to continue to mitigate ongoing inflationary pressures. I’m pleased with our teams’ marketplace execution, which has continued to gain momentum throughout the year and sets us up for continued strong growth ahead.”

Full-year 2018 Outlook

Xylem continues to forecast full-year 2018 revenue of approximately $5.2 billion, up approximately 10 percent versus the prior year, including growth from previously announced acquisitions. On an organic basis, Xylem now anticipates revenue growth in the range of seven to eight percent.

Xylem has narrowed the range of its full-year 2018 earnings expectations to reflect the Company’s strong operational performance year-to-date and the negative impact of foreign exchange translation. Full-year 2018 adjusted operating margin is now expected to be in the range of 13.9 to 14.0 percent, resulting in adjusted earnings per share of $2.87 to $2.89. This represents an increase of approximately 20 percent from Xylem’s 2017 adjusted results. The Company’s adjusted earnings outlook excludes projected integration, restructuring and realignment costs, which are expected to be approximately $45 million for the year. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Third Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

  • Third quarter 2018 revenue was $541 million, up eight percent organically compared with third quarter 2017. This growth includes an eight-percent increase in the utilities end market, which continues to show strength, particularly in Emerging Markets and North America. The industrial end market delivered mid-single-digit growth, driven by growing demand for Xylem’s dewatering applications in construction, mining and the oil and gas sector.
  • Third quarter reported operating income for the segment was $99 million. Adjusted operating income for the segment, which excludes $5 million of restructuring and realignment costs, was $104 million, an 11-percent increase over the same period a year ago. Adjusted EBITDA margin for the Water Infrastructure segment increased 120 basis points to 22.2 percent. Reported operating margin for the segment was 18.3 percent, up 80 basis points versus the prior year, and adjusted operating margin increased 110 basis points to 19.2 percent. This growth reflects productivity gains, volume leverage and price realization, partially offset by inflation and higher investments in strategic growth initiatives.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial applications.

  • Third quarter 2018 Applied Water revenue was $378 million, an eight-percent increase organically year over year. This performance reflects high-single-digit growth in the U.S., Western Europe and Emerging Markets. Strength in the commercial end market was driven by project activity as well as market share gains in U.S. and Europe. The Company’s business in the industrial end market was particularly strong in the U.S., driven by healthy project business.
  • Third quarter reported operating income for the segment was $59 million and adjusted operating income, which excludes $2 million of restructuring and realignment costs, was $61 million, an 11-percent increase over the comparable period last year. Adjusted EBITDA margin for the Applied Water segment was 18 percent, an increase of 50 basis points over the prior year. Reported operating margin was 15.6 percent, up 150 basis points year over year, and adjusted operating margin increased 60 basis points to 16.1 percent as productivity initiatives, price realization and volume leverage more than offset inflation and unfavorable foreign exchange impacts.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

  • Third quarter 2018 Measurement & Control Solutions revenue was $368 million, up eight percent organically versus the prior year period. This reflects solid growth in the Sensus business, up high single digits year over year, driven by large project deployments in the gas sector and double-digit growth in the water sector in North America.
  • Third quarter reported operating income for the segment was $31 million, and adjusted operating income, which excludes $4 million of restructuring and realignment costs and acquisition-related costs, was $35 million, a nine-percent increase over the prior-year period. Adjusted EBITDA margin for the Measurement & Control Solutions segment increased 90 basis points to 19 percent. Reported operating margin for the segment was 8.4 percent, flat versus the prior year period. The benefits of volume leverage and productivity initiatives were more than offset by the funding of strategic growth investments, inflation and purchase accounting. This resulted in a 50-basis-point decrease in adjusted operating margin to 9.5 percent.

Supplemental information on Xylem’s third quarter 2018 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s more than 16,500 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York with 2017 revenue of $4.7 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

These forward-looking statements include statements about the capitalization of Xylem Inc. (the “Company”), the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future – including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results – are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements. Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions, political and other risks associated with our international operations, including military actions, economic sanctions or trade barriers and embargoes that could affect customer markets, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; ability to retain and attract talent and key members of management; our relationship with and the performance of our channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; governmental investigations; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2017, and those described from time to time in subsequent reports filed with the Securities and Exchange Commission. Forward-looking statements made herein are based on information currently available to the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

   
Three Months Nine Months
For the periods ended September 30, 2018   2017 2018   2017
Revenue $ 1,287 $ 1,195 $ 3,821 $ 3,430
Cost of revenue 782   724   2,337   2,090
Gross profit 505 471 1,484 1,340
Selling, general and administrative expenses 279 270 868 812
Research and development expenses 46 45 137 131
Restructuring and asset impairment charges, net 4   4   19   22
Operating income 176 152 460 375
Interest expense 21 21 63 62
Other non-operating income (expense), net 4 1 9 5
Gain (loss) from sale of business 2   (1 )   4
Income before taxes 161 131 406 322
Income tax expense 31     27   82     62
Net income 130 104 324 260
Less: Net loss attributable to non-controlling interests   (1 )  
Net income attributable to Xylem $ 130   $ 105   $ 324   $ 260
Earnings per share:
Basic $ 0.73 $ 0.58 $ 1.80 $ 1.45
Diluted $ 0.72 $ 0.58 $ 1.79 $ 1.44
Weighted average number of shares:
Basic 179.7 179.6 179.8 179.6
Diluted 181.1 180.9 181.2 180.7
Dividends declared per share $ 0.2100 $ 0.1800 $ 0.6300 $ 0.5400
 
 
XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

   
September 30, December 31,
    2018 2017
 
ASSETS
Current assets:
Cash and cash equivalents $ 404 $ 414
Receivables, less allowances for discounts and doubtful accounts of $34 and $35 in 2018 and 2017, respectively 1,017 956
Inventories 622 524
Prepaid and other current assets 161   177  
Total current assets 2,204 2,071
Property, plant and equipment, net 636 643
Goodwill 3,008 2,768
Other intangible assets, net 1,259 1,168
Other non-current assets 219   210  
Total assets $ 7,326   $ 6,860  
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 570 $ 549
Accrued and other current liabilities 571 551
Short-term borrowings and current maturities of long-term debt 342    
Total current liabilities 1,483 1,100
Long-term debt 2,189 2,200
Accrued postretirement benefits 409 442
Deferred income tax liabilities 284 252
Other non-current accrued liabilities 330   347  
Total liabilities 4,695   4,341  
 
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 192.9 shares and 192.3 shares in 2018 and 2017, respectively 2 2
Capital in excess of par value 1,942 1,912
Retained earnings 1,452 1,227
Treasury stock – at cost 13.2 shares and 12.4 shares in 2018 and 2017, respectively (486 ) (428 )
Accumulated other comprehensive loss (293 ) (210 )
Total stockholders’ equity 2,617   2,503  
Non-controlling interests 14 16
Total equity 2,631   2,519  
Total liabilities and stockholders’ equity $ 7,326   $ 6,860  
 
 
XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

 
For the nine months ended September 30, 2018   2017
Operating Activities
Net income $ 324 $ 260
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 87 83
Amortization 108 91
Share-based compensation 23 16
Restructuring and asset impairment charges 19 22
Loss (gain) from sale of business (4 )
Other, net 2 18
Payments for restructuring (18 ) (25 )
Changes in assets and liabilities (net of acquisitions):
Changes in receivables (76 ) (114 )
Changes in inventories (115 ) (14 )
Changes in accounts payable 51 3
Other, net (17 ) 43  
Net Cash – Operating activities 388   379  
Investing Activities
Capital expenditures (171 ) (119 )
Acquisitions of businesses, net of cash acquired (433 ) (16 )
Proceeds from sale of assets and business 22 11
Cash received from investments 10
Cash paid for investments (11 )
Other, net 3   3  
Net Cash – Investing activities (579 ) (122 )
Financing Activities
Short-term debt issued, net 410
Short-term debt repaid (50 ) (184 )
Repurchase of common stock (58 ) (25 )
Proceeds from exercise of employee stock options 7 8
Dividends paid (114 ) (97 )
Other, net   (1 )
Net Cash – Financing activities 195   (299 )
Effect of exchange rate changes on cash (14 ) 17  
Net change in cash and cash equivalents (10 ) (25 )
Cash and cash equivalents at beginning of year 414   308  
Cash and cash equivalents at end of period $ 404   $ 283  
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest $ 47 $ 46
Income taxes (net of refunds received) $ 60 $ 58
 
 
Xylem Inc. Non-GAAP Measures
 
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:
 
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
 
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
 
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, Sensus acquisition related costs, gain or loss from sale of businesses and special charges.
 
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, adjusted net income and earnings per share, adjusted to exclude restructuring and realignment costs, Sensus acquisition related costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
 
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
 
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
 
“Sensus Acquisition Related Costs" defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.
 
“Special charges" defined as costs incurred by the Company, such as non-cash impairment charges, acquisition and integration related costs not related to Sensus, due diligence costs and other special non-operating items.
 
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.
 
 
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders
($ Millions)
                                     
(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
  (A)   (B)   (C)   (D)   (E) = B+C+D   (F) = E/A (G) = (E - C) / A
 
Change % Change

Acquisitions /

Change % Change
Orders Orders

2018 v. 2017

2018 v. 2017

Divestitures

FX Impact

Adj. 2018 v. 2017

Adj. 2018 v. 2017
2018 2017

Nine Months Ended September 30

 
Xylem Inc. 4,054 3,598 456 13 % (69 ) (62 ) 325 9 % 11 %
 
Water Infrastructure 1,671 1,546 125 8 % - (25 ) 100 6 % 6 %
Applied Water 1,162 1,103 59 5 % 12 (18 ) 53 5 % 4 %
Measurement & Control Solutions 1,221 949 272 29 % (81 ) (19 ) 172 18 % 27 %
 

Quarter Ended September 30

 
Xylem Inc. 1,356 1,249 107 9 % (27 ) 24 104 8 % 10 %
 
Water Infrastructure 537 558 (21 ) -4 % - 17 (4 ) -1 % -1 %
Applied Water 377 374 3 1 % 2 5 10 3 % 2 %
Measurement & Control Solutions 442 317 125 39 % (29 ) 2 98 31 % 40 %
 

Quarter Ended June 30

 
Xylem Inc. 1,378 1,212 166 14 % (34 ) (30 ) 102 8 % 11 %
 
Water Infrastructure 580 521 59 11 % - (14 ) 45 9 % 9 %
Applied Water 401 375 26 7 % 4 (9 ) 21 6 % 5 %

Measurement & Control Solutions

397 316 81 26 % (38 ) (7 ) 36 11 % 23 %
 

Quarter Ended March 31

 
Xylem Inc. 1,320 1,137 183 16 % (8 ) (56 ) 119 10 % 11 %
 
Water Infrastructure 554 467 87 19 % - (28 ) 59 13 % 13 %
Applied Water 384 354 30 8 % 6 (14 ) 22 6 % 5 %
Measurement & Control Solutions 382 316 66 21 % (14 ) (14 ) 38 12 % 16 %
 
 
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
                                   
(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
  (A)   (B)   (C)   (D)   (E) = B+C+D   (F) = E/A (G) = (E - C) / A
 
Change % Change

Acquisitions /

Change % Change
Revenue Revenue 2018 v. 2017 2018 v. 2017

Divestitures

FX Impact Adj. 2018 v. 2017 Adj. 2018 v. 2017
2018 2017

Nine Months Ended September 30

 
Xylem Inc. 3,821 3,430 391 11 % (63 ) (59 ) 269 8 % 10 %
 
Water Infrastructure 1,567 1,421 146 10 % - (20 ) 126 9 % 9 %
Applied Water 1,132 1,048 84 8 % 10 (18 ) 76 7 % 6 %
Measurement & Control Solutions 1,122 961 161 17 % (73 ) (21 ) 67 7 % 15 %
 

Quarter Ended September 30

 
Xylem Inc. 1,287 1,195 92 8 % (22 ) 24 94 8 % 10 %
 
Water Infrastructure 541 520 21 4 % - 18 39 8 % 8 %
Applied Water 378 354 24 7 % 2 4 30 8 % 8 %
Measurement & Control Solutions 368 321 47 15 % (24 ) 2 25 8 % 15 %
 

Quarter Ended June 30

 
Xylem Inc. 1,317 1,164 153 13 % (26 ) (29 ) 98 8 % 11 %
 
Water Infrastructure 546 482 64 13 % - (13 ) 51 11 % 11 %
Applied Water 388 361 27 7 % 3 (8 ) 22 6 % 5 %
Measurement & Control Solutions 383 321 62 19 % (29 ) (8 ) 25 8 % 17 %
 

Quarter Ended March 31

 
Xylem Inc. 1,217 1,071 146 14 % (15 ) (54 ) 77 7 % 9 %
 
Water Infrastructure 480 419 61 15 % - (25 ) 36 9 % 9 %
Applied Water 366 333 33 10 % 5 (14 ) 24 7 % 6 %
Measurement & Control Solutions 371 319 52 16 % (20 ) (15 ) 17 5 % 12 %
 
 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)
                                 
Q1 Q2 Q3 YTD
2018   2017 2018   2017 2018   2017 2018   2017
Total Revenue
• Total Xylem 1,217 1,071 1,317 1,164 1,287 1,195 3,821 3,430
• Water Infrastructure 480 419 546 482

 

541 520 1,567 1,421
• Applied Water 366 333 388 361

 

378 354 1,132 1,048
• Measurement & Control Solutions 371 319 383 321 368 321 1,122 961
                                 
Operating Income
• Total Xylem 113 86 171 137 176 152 460 375
• Water Infrastructure 49 41 92 74

 

99 91 240 206
• Applied Water 50 36 61 48

 

59 50 170 134
• Measurement & Control Solutions 33 25 31 29 31 27 95 81
• Total Segments 132 102 184 151 189 168 505 421
 
Operating Margin
• Total Xylem 9.3% 8.0% 13.0% 11.8% 13.7% 12.7% 12.0% 10.9%
• Water Infrastructure 10.2% 9.8% 16.8% 15.4% 18.3% 17.5% 15.3% 14.5%
• Applied Water 13.7% 10.8% 15.7% 13.3% 15.6% 14.1% 15.0% 12.8%
• Measurement & Control Solutions 8.9% 7.8% 8.1% 9.0% 8.4% 8.4% 8.5% 8.4%
• Total Segments   10.8%   9.5%   14.0%   13.0%   14.7%   14.1%   13.2%   12.3%
 
Sensus Acquisition Related Costs
• Total Xylem - 10 - 4 - 5 - 19
• Water Infrastructure - - - - - - - -
• Applied Water - - - - - - - -
• Measurement & Control Solutions - 6 - 3 - 4 - 13
• Total Segments - 6 - 3 - 4 - 13
 
Special Charges
• Total Xylem 6 5 1 - 1 3 8 8
• Water Infrastructure - - - - - - -
• Applied Water - 5 - - - - 5
• Measurement & Control Solutions 2 - 1 - - - 3 -
• Total Segments 2 5 1 - - - 3 5
 
Restructuring & Realignment Costs
• Total Xylem 16 11 10 12 11 9 37 32
• Water Infrastructure 5 4 5 5 5 3 15 12
• Applied Water 3 4 2 5 2 5 7 14
• Measurement & Control Solutions 8 3 3 2 4 1 15 6
• Total Segments 16 11 10 12 11 9 37 32
                                 
Adjusted Operating Income
• Total Xylem 135 112 182 153 188 169 505 434
• Water Infrastructure 54 45 97 79

 

104 94 255 218
• Applied Water 53 45 63 53

 

61 55 177 153
• Measurement & Control Solutions 43 34 35 34

 

35 32 113 100
• Total Segments 150 124 195 166 200 181 545 471
 
Adjusted Operating Margin
• Total Xylem 11.1% 10.5% 13.8% 13.1% 14.6% 14.1% 13.2% 12.7%
• Water Infrastructure 11.3% 10.7% 17.8% 16.4% 19.2% 18.1% 16.3% 15.3%
• Applied Water 14.5% 13.5% 16.2% 14.7% 16.1% 15.5% 15.6% 14.6%
• Measurement & Control Solutions 11.6% 10.7% 9.1% 10.6% 9.5% 10.0% 10.1% 10.4%
• Total Segments   12.3%   11.6%   14.8%   14.3%   15.5%   15.1%   14.3%   13.7%
 
  Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
 
 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
 
                         
Q3 2018 Q3 2017
As Reported   Adjustments Adjusted As Reported   Adjustments Adjusted
Total Revenue 1,287 1,287 1,195 1,195
Operating Income 176 12 a 188 152 17 a 169
Operating Margin 13.7 % 14.6 % 12.7 % 14.1 %
Interest Expense (21 ) (21 ) (21 ) (21 )
Other Non-Operating Income (Expense) 4 4 1 1
Gain/(Loss) From Sale of Businesses   2     (2 )   -     (1 )   1     -  
Income before Taxes 161 10 171 131 18 149
Provision for Income Taxes (31 ) (1 ) b (32 ) (27 ) (4 ) b (31 )
Income Attributable to Minority Interest       -     1       1  
Net Income Attributable to Xylem   130     9     139     105     14     119  
Diluted Shares     181.1           181.1       180.9           180.9  
Diluted EPS   $ 0.72     $ 0.05     $ 0.77     $ 0.58     $ 0.07     $ 0.65  
 
Year-over-year currency translation impact on current year diluted EPS   $ (0.01 )   $ (0.01 )   $ (0.02 )
Diluted EPS at Constant Currency   $ 0.73     $ 0.06     $ 0.79  
 
                   
Q3 YTD 2018 Q3 YTD 2017

As Reported

Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue 3,821 3,821 3,430 3,430
Operating Income 460 45 a 505 375 59 a 434
Operating Margin 12.0 % 13.2 % 11.0 % 12.7 %
Interest Expense (63 ) (63 ) (62 ) (62 )
Other Non-Operating Income (Expense) 9 9 5 5
Gain/(Loss) From Sale of Businesses   -     -     -     4     (4 )   -  
Income before Taxes 406 45 451 322 55 377
Provision for Income Taxes (82 ) (6 ) b (88 ) (62 ) (19 ) b (81 )
Income Attributable to Minority Interest   -       -     -       -  
Net Income Attributable to Xylem   324     39     363     260     36     296  
Diluted Shares     181.2           181.2       180.7           180.7  
Diluted EPS   $ 1.79     $ 0.21     $ 2.00     $ 1.44     $ 0.20     $ 1.64  
 
Year-over-year currency translation impact on current year diluted EPS   $ 0.07     $ -     $ 0.07  
Diluted EPS at Constant Currency   $ 1.72     $ 0.21     $ 1.93  
 
  Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
 
a QTD: Restructuring & realignment costs of $11 million and $9 million in 2018 and 2017, respectively; special charges of $1 million of acquisition related costs in 2018 and $3 million of due diligence costs in 2017; and $5 million of Sensus acquisition related costs in 2017.
YTD: Restructuring & realignment costs of $37 million and $32 million in 2018 and 2017, respectively; special charges of $8 million of acquisition related costs in 2018 and $5 million of asset impairment and $3 million of due diligence costs in 2017; and 2017 Sensus acquisition related costs of $19 million.
 
b

QTD: Net tax impact on restructuring & realignment costs of $3 million and $4 million in 2018 and 2017, respectively; net tax impact on 2017 Sensus acquisition related costs of $2 million and special charges of $1 million; and tax-related special items of $2 million of benefit and $3 million of benefit in 2018 and 2017, respectively.

YTD: Net tax impact on restructuring & realignment costs of $10 million and $11 million in 2018 and 2017, respectively; net tax impact on special charges of $1 million and $3 million in 2018 and 2017, respectively; net tax impact of $7 million on 2017 Sensus acquisition related costs; net tax impact of $2 million on the gain from sale of business in 2017; and tax-related special items of $5 million of benefit and $0 million in 2018 and 2017, respectively.
 
 
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow
($ Millions)
 
  Q1   Q2   Q3   Nine Months Ended
2018   2017 2018   2017 2018   2017 2018   2017
 
Net Cash - Operating Activities $ 63 $ 52 $ 138 $ 99 $ 187 $ 228 $ 388 $ 379
 
Capital Expenditures (61 ) (43 ) (50 ) (34 ) (60 ) (42 ) (171 ) (119 )
               
Free Cash Flow $ 2   $ 9   $ 88   $ 65   $ 127   $ 186   $ 217   $ 260  
 
Cash paid for Sensus acquisition related costs (1 ) (17 ) - (5 ) - (1 ) (1 ) (23 )
               
Free Cash Flow, excluding Sensus Acquisition Related Costs $ 3   $ 26   $ 88   $ 70   $ 127   $ 187   $ 218   $ 283  
 
Net Income 79 56 115 100 130 104 324 260
 
Gain/(Loss) from sale of businesses - 5 (2 ) - 2 (1 ) - 4
 
Special Charges - non-cash impairment - (5 ) - - - - - (5 )
 
Sensus acquisition related costs   -     (10 )   -     (4 )   -     (5 )   -     (19 )
 
Net Income, excluding gain on sale of businesses, non-cash impairment charges and Sensus Acquisition Related Costs $ 79   $ 66   $ 117   $ 104   $ 128   $ 110   $ 324   $ 280  
 
Free Cash Flow Conversion   4 %   39 %   75 %   67 %   99 %   170 %   67 %   101 %
 
 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
 
($ Millions)
 

 

 

2018

   
Q1   Q2   Q3 Q4 Total
 
Net Income 79 115 130 324
 
Income Tax Expense 16 35 31 82
 
Interest Expense (Income), net 20 20 20 60
Depreciation 29 29 29 87
Amortization 38   36   34     108  
EBITDA 182 235 244 - 661
 
Share-based Compensation 9 7 7 23
 
Restructuring & Realignment 16 9 11 36
 
Loss/(Gain) from sale of business - 2 (2 ) -
 
Special Charges 6 1 1 8
         
Adjusted EBITDA 213   254   261   -   728  
 
Revenue 1,217   1,317   1,287     3,821  
 
Adjusted EBITDA Margin 17.5 % 19.3 % 20.3 %   19.1 %
 

 

2017

Q1 Q2 Q3 Q4 Total
 
Net Income 56 100 104 70 330
 
Income Tax Expense 14 21 27 74 136
 
Interest Expense (Income), net 20 20 20 19 79
Depreciation 28 27 28 26 109
Amortization 31   30   30   34   125  
EBITDA 149 198 209 223 779
 
Share-based Compensation 6 5 5 5 21
 
Restructuring & Realignment 11 12 9 9 41
 
Loss/(Gain) from sale of business (5 ) - 1 14 10
 
Sensus Acquisition Related Costs 7 2 3 2 14
 
Special Charges 5 - 3 5 13
         
Adjusted EBITDA 173   217   230   258   878  
 
Revenue 1,071   1,164   1,195   1,277   4,707  
 
Adjusted EBITDA Margin 16.2 % 18.6 % 19.2 % 20.2 % 18.7 %
 
 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Water Infrastructure
($ Millions)
 

 

 

2018

   
Q1   Q2   Q3 Q4 Total
 
Pre-Tax Income 47 90 98 235
 
Interest Expense (Income), net - (1 ) (1 ) (2 )
Depreciation 12 11 12 35
Amortization 5   5   5     15  
EBITDA 64 105 114 - 283
 
Share-based Compensation 1 - 1 2
 
Restructuring & Realignment 5 5 5 15
         
Adjusted EBITDA 70   110   120   -   300  
 
Revenue 480   546   541     1,567  
 
Adjusted EBITDA Margin 14.6 % 20.1 % 22.2 %   19.1 %
 
 

 

2017

Q1 Q2 Q3 Q4 Total
 
Pre-Tax Income 39 73 90 105 307
 
Interest Expense (Income), net - - (1 ) (1 ) (2 )
Depreciation 11 11 12 11 45
Amortization 5   4   5   5   19  
EBITDA 55 88 106 120 369
 
Share-based Compensation 1 - - 1 2
 
Restructuring & Realignment 4 5 3 4 16
         
Adjusted EBITDA 60   93   109   125   387  
 
Revenue 419   482   520   583   2,004  
 
Adjusted EBITDA Margin 14.3 % 19.3 % 21.0 % 21.4 % 19.3 %
 
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
 
 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Applied Water
($ Millions)
 

 

 

2018

   
Q1   Q2   Q3 Q4 Total
 
Pre-Tax Income 50 61 60 171
 
Interest, net - - - -
Depreciation 5 5 5 15
Amortization -   1   1     2  
EBITDA 55 67 66 - 188
 
Share-based Compensation 1 1 - 2
 
Restructuring & Realignment 3 2 2 7
         
Adjusted EBITDA 59   70   68   -   197  
 
Revenue 366   388   378     1,132  
 
Adjusted EBITDA Margin 16.1 % 18.0 % 18.0 %   17.4 %
 
 

 

2017

Q1 Q2 Q3 Q4 Total
 
Pre-Tax Income 40 49 49 62 200
 
Interest, net - - - - -
Depreciation 5 5 5 5 20
Amortization 1   1   1   -   3  
EBITDA 46 55 55 67 223
 
Share-based Compensation - 1 1 - 2
 
Restructuring & Realignment 4 5 5 3 17
 
Loss/(Gain) from sale of business (5 ) - 1 (2 ) (6 )
 
Special Charges 5 - - - 5
         
Adjusted EBITDA 50   61   62   68   241  
 
Revenue 333   361   354   373   1,421  
 
Adjusted EBITDA Margin 15.0 % 16.9 % 17.5 % 18.2 % 17.0 %
 
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.
 
 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Measurement & Control Solutions
($ Millions)
 

 

 

2018

   
Q1   Q2   Q3 Q4 Total
 
Pre-Tax Income 33 28 33 94
 
Interest Expense (Income), net - - - -
Depreciation 8 9 8 25
Amortization 29   27   26     82  
EBITDA 70 64 67 - 201
 
Share-based Compensation 1 1 1 3
 
Restructuring & Realignment 8 3 4 15
 
Loss/(Gain) from sale of business - 2 (2 ) -
 
Special Charges 2 1 - 3
         
Adjusted EBITDA 81   71   70   -   222  
 
Revenue 371   383   368     1,122  
 
Adjusted EBITDA Margin 21.8 % 18.5 % 19.0 %   19.8 %
 

 

2017

Q1 Q2 Q3 Q4 Total
 
Pre-Tax Income 24 30 26 11 91
 
Interest Expense (Income), net - - - (1 ) (1 )
Depreciation 8 8 7 7 30
Amortization 23   22   22   25   92  
EBITDA 55 60 55 42 212
 
Share-based Compensation - 1 - 1 2
 
Restructuring & Realignment 3 2 1 2 8
 
Loss from sale of business - - - 16 16
 
Sensus Acquisition Related Costs 3 1 2 1 7
 
Special Charges - - - 2 2
         
Adjusted EBITDA 61   64   58   64   247  
 
Revenue 319   321   321   321   1,282  
 
Adjusted EBITDA Margin 19.1 % 19.9 % 18.1 % 19.9 % 19.3 %
 
Note: 2017 amounts have been restated in accordance with the adoption of the new guidance on presentation of net periodic benefit costs.

Source: Xylem Inc.

Xylem Inc.
Media
Kelly McAndrew +1 (914) 323-5969
Kelly.McAndrew@xyleminc.com
or
Investors
Matt Latino +1 (914) 323-5821
Matthew.Latino@xyleminc.com